Get 15% off your first order from Blue Sky Vitamin
Brazil approves first generic semaglutide pen after Ozempic patent expiry SAO PAULO, May 26 (Reuters) - Brazil's health regulator Anvisa said on Tuesday it had approved EMS's Ozivy, the country's first semaglutide-based injector pen, as the drugmaker looks to expand into a higher-end segment of the global pharmaceutical industry
Our Personalized Weight Loss Program: Your Path to a Healthier You For those seeking a structured and medically supervised approach to weight loss, our personalized program offers a robust framework
Why this Matters : Popular science coverage captured the shift by noting that a 60yearold diabetes drug also acts within the brain, as reported by ScienceAlert
If you're unwell, consider checking for ketones, especially if your glucose is elevated
What strategies do you recommend